Byshevskiĭ A Sh, Mukhacheva I A
Biokhimiia. 1976 Mar;41(3):543-7.
A lipoid anticoagulant (LA) from human brain tissue was shown to possess a higher anticoagulant activity than previously obtained preparations. It has been established that out of four phospholipids present in LA, only phosphatidyl serine inhibits the coagulant activity of plasma. In isolated hemocoagulating systems LA and phosphatidyl serine were shown to inhibit prothrombin conversion catalyzed by thrombokinase and to exert the antithrombic action in the system thrombin--fibrinogen. Kinetic study of phosphatidyl serine- and LA-induced inhibition of thrombine formation and the thrombine--fibrinogen reaction by conjugated inhibition. Similar kinetic behaviour, observed upon inhibition of both processes by phosphatidyl serine and LA suggest that phosphatidyl serine is a main anticoagulant agent of LA.
从人脑组织中提取的一种类脂抗凝剂(LA),其抗凝活性高于以往制备的制剂。现已确定,在LA中存在的四种磷脂中,只有磷脂酰丝氨酸能抑制血浆的凝血活性。在分离的凝血系统中,LA和磷脂酰丝氨酸可抑制凝血激酶催化的凝血酶原转化,并在凝血酶-纤维蛋白原系统中发挥抗血栓作用。通过共轭抑制对磷脂酰丝氨酸和LA诱导的凝血酶形成抑制以及凝血酶-纤维蛋白原反应进行动力学研究。磷脂酰丝氨酸和LA对这两个过程的抑制呈现相似的动力学行为,这表明磷脂酰丝氨酸是LA的主要抗凝剂。